UGT

UGT
Name	UDP-glucuronosyltransferase
EC	2.4.1.17
Alternative names	UDP-glucuronosyltransferases, UGTs
System	Xenobiotic metabolism
Cofactors	UDP-glucuronic acid
Location	Endoplasmic reticulum

UGT

UDP-glucuronosyltransferases are a family of enzymes that catalyze glucuronidation, a major biotransformation pathway that conjugates glucuronic acid to small molecules. Members participate in metabolism of endogenous compounds and xenobiotics, affecting pharmacokinetics and toxicity profiles across species. This article outlines nomenclature, structural determinants, tissue distribution, physiological substrates, clinical genetics, and laboratory approaches used to study these enzymes.

Introduction

UDP-glucuronosyltransferases belong to a conserved enzyme family present in vertebrates, invertebrates, plants, and microbes, and play central roles in clearance pathways characterized in studies involving David S. Breslow, Paul Ehrlich, Louis Pasteur, Linus Pauling, Gertrude Elion. Research on UGTs intersects with investigations by teams at institutions such as National Institutes of Health, Food and Drug Administration, European Medicines Agency, Cambridge University, Harvard University. Prominent enzyme characterization papers cite landmark reports from laboratories at University of California, San Francisco, University of Oxford, Karolinska Institutet, Max Planck Society, and Riken.

Nomenclature and Enzyme Family

UGTs are classified into families and subfamilies based on sequence homology, with human forms grouped primarily in family 1 and family 2. Key human isoforms include the UGT1A cluster and UGT2B members characterized in genomic studies from groups at Wellcome Trust Sanger Institute, National Human Genome Research Institute, Broad Institute, Cold Spring Harbor Laboratory, and European Bioinformatics Institute. Nomenclature conventions emerged from consensus panels involving representatives of International Union of Biochemistry and Molecular Biology, Human Genome Organization, American Society for Pharmacology and Experimental Therapeutics, Society for Toxicology, and regulatory agencies such as EMA and FDA.

Structure and Mechanism

UGTs are membrane-associated glycoproteins anchored in the endoplasmic reticulum via a transmembrane helix; crystal and cryo-EM structural efforts draw on techniques developed at Stanford University, MIT, ETH Zurich, Max Planck Institute for Biophysical Chemistry, and Scripps Research. The catalytic mechanism involves nucleophilic attack by a substrate hydroxyl, amine, or carboxyl group on the anomeric carbon of UDP-glucuronic acid, a reaction studied alongside mechanisms elucidated for glycosyltransferase family 1, glycosyltransferase family 2, GT-B fold enzymes and compared with paradigms from beta-glucuronidase investigations. Active site residues and donor-binding motifs are conserved among UGTs, informed by mutagenesis work from laboratories at Yale University, Columbia University, University of Tokyo, and McGill University.

Tissue Distribution and Regulation

Expression profiles show isoform-specific distribution: hepatic, intestinal, renal, pulmonary, cerebral, and reproductive tissues express distinct sets. Transcriptomic and proteomic surveys employing platforms developed by Illumina, Thermo Fisher Scientific, Agilent Technologies, and consortia such as GTEx Project, ENCODE Project, and Human Protein Atlas mapped tissue-specific patterns. Regulation occurs via nuclear receptors and signal transduction pathways studied in the context of Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor, Glucocorticoid Receptor, and hormones explored by groups at Johns Hopkins University, University of Edinburgh, and Institut Pasteur.

Physiological Roles and Substrates

UGTs conjugate bilirubin, steroid hormones, bile acids, neurotransmitters, and many pharmaceuticals. Classic substrates and pathways tie to discoveries involving Jaundice research from Robert Roediger, Ishihara Satoshi, and bilirubin metabolism studies at Children's Hospital Medical Center (Boston). Drug substrates span classes characterized in pharmacology by Paul Ehrlich-era and modern drug discovery programs at Pfizer, GlaxoSmithKline, Novartis, Roche, and AstraZeneca. Endogenous targets include estradiol, testosterone, thyroxine derivatives, and serotonin metabolites; clinical implications connect to syndromes studied at Mayo Clinic, Cleveland Clinic, and Karolinska University Hospital.

Clinical Significance and Genetic Variants

Variants in UGT genes underlie clinical phenotypes such as hyperbilirubinemia syndromes and altered drug clearance. Notable genetic associations stem from studies on promoter polymorphisms and coding variants identified by consortia like 1000 Genomes Project, HapMap Project, ClinVar, and laboratories at University of Cambridge School of Clinical Medicine and Imperial College London. Pharmacogenetic guidelines referencing UGT polymorphisms are issued by organizations including Clinical Pharmacogenetics Implementation Consortium, European Society for Clinical Pharmacology and Therapeutics, and affect dosing recommendations for drugs developed by firms like Bristol-Myers Squibb and Eli Lilly and Company. Rare pathogenic variants producing severe phenotypes have been reported in case series from tertiary centers including Great Ormond Street Hospital and St. Jude Children's Research Hospital.

Research Methods and Applications

Experimental approaches include recombinant expression in systems pioneered by Escherichia coli research at Pasteur Institute and eukaryotic systems used by groups at Baylor College of Medicine, DNAX Research Institute, and Roche. Assays utilize mass spectrometry platforms by Thermo Fisher, Waters Corporation, and Agilent, along with high-throughput screening strategies from Broad Institute and Scripps Research. Applications span drug development, environmental toxicology studies led by Environmental Protection Agency, biomarker discovery in clinical trials overseen by National Cancer Institute, and evolutionary analyses performed by teams at Smithsonian Institution.

Category:Enzymes